GlassScriptPhysician profile
Richard D Wagner
NPI 1114337334
$728.98
in general payments reported to CMS, 2019-2025
20 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $70.44 · 2021: $39.62 · 2022: $131 · 2023: $81.39 · 2024: $92.79 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $119.05 | 2019-2023 | Lo Loestrin Fe |
| Shield Therapeutics INC | $112.59 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.00 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $72.85 | 2023-2025 | |
| Organon LLC | $52.73 | 2025 | Nexplanon |
| Exeltis, USA INC. | $35.77 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $30.06 | 2019 | |
| Myovant Sciences INC. | $22.35 | 2022 | |
| Genzyme Corporation | $20.38 | 2019 | |
| Evofem Biosciences, INC. | $20.20 | 2021 | |
| Scynexis, INC. | $19.93 | 2022 | |
| Merck Sharp & Dohme LLC | $19.84 | 2020 | |
| Amgen INC. | $18.64 | 2019 | |
| Coopersurgical, INC. | $18.12 | 2025 | |
| Agile Therapeutics, INC. | $17.63 | 2023 | Twirla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $17.27 | 2025 | Zurzuvae |
| Mission Pharmacal Company | $14.89 | 2020 | |
| Tersera Therapeutics LLC | $14.80 | 2019 | |
| Therapeuticsmd, INC. | $13.06 | 2019 | |
| Exelixis INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.